Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Transpose Platform is a global venture capital fund based in the United States, founded to support early-stage companies and the funds that accelerate them. The firm targets investments at the pre-seed, seed, seed-plus, and Series A stages, focusing on cultivating category-defining companies. Their portfolio spans multiple sectors, indicating a broad investment strategy.
Transpose Platform invests in early-stage companies across sectors such as AI, biotech, climate tech, consumer products, fintech, and healthcare. The firm aims to cultivate category-defining companies by focusing on innovative solutions that address significant market needs. Investments typically occur at the pre-seed to Series A stages, with a global reach and particular emphasis on the U.S. market.
Transpose Platform's portfolio includes notable companies such as Agentic Labs and A51 in AI and biotech, respectively. Other investments span sectors like fintech with Acko and April Tax, and healthcare with AccuRx and Anqalab.
Submit your pitch through their form at transposeplatform.vc.
Transpose Platform often leads investment rounds, particularly in the early stages, to provide substantial support to founders.
The firm is open to follow-on investments, especially for companies that demonstrate strong growth and alignment with their investment thesis.
Specific fund size details are not publicly disclosed, but the firm focuses on early-stage investments across multiple sectors.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.